Abstract
Simple SummaryMelanin content in uveal melanoma is suspected to influence tumoral microenvironment and antitumoral response and is related to higher risk of metastasis and death in the primary disease. However, the prognostic impact of melanin content in liver metastases of uveal melanoma (LMUM) remains unexplored. The aim of our retrospective study was to evaluate the prognostic implications of melanin quantification assessed by MRI with clinical, pathological, and genetic features of LMUM. We found in a population of 63 patients eligible for margin-free resection of LMUM that MRI melanin quantification was an independent prognostic factor associated with overall survival. Liver metastases with high MRI melanin content and high genetic risk “M3/8g” were associated with lower overall survival compared with that of liver metastases with low MRI melanin content and/or low/intermediate genetic risk. The level of pigmentation in “M3/8g” LMUM identified two subsets that were correlated with distinct clinical outcomes.To evaluate the prognostic implications of melanin quantification assessed by magnetic resonance imaging (MRI) with respect to the clinical, pathological, and genetic features of liver metastases of uveal melanoma (LMUM). This single-center retrospective cohort study included 63 patients eligible for margin-free resection of LMUM between 2007 and 2018. Comparative genomic hybridization of resected liver metastases on microarrays was performed for genetic risk classification. Metastases exhibiting monosomy 3 with any type of gain of chromosome 8 (M3/8g) were considered high-genetic-risk. MRI melanin quantification using the mean T1 signal (mT1s) in liver metastases was assessed quantitatively on preoperative imaging examination and compared to that of gross pathological evaluation. The association between MRI melanin quantification and overall survival (OS) was assessed by multivariate analysis using the Cox proportional hazards model. Gross pathological assessment of melanin content and MRI melanin quantification were strongly correlated (r = 0.8, p < 0.001). Independent prognostic factors associated with OS were disease-free interval ≤ 24 months (HR = 3.1; 95% CI, 1.6–6.0; p < 0.001), high-genetic-risk (HR = 2.2; 95% CI, 1.1–4.8; p = 0.04), mT1s > 1.1 (HR = 2.3; 95% CI, 1.2–4.7; p = 0.019), and complete hepatic resection (HR = 0.3; 95% CI, 0.2–0.7; p = 0.004). In patients with high-genetic-risk, mT1s showed a significant association with OS (HR = 3.7; 95% CI, 1.5–9.3; p = 0.006). The median OS was 17.5 months vs. 27 months for >1.1 and ≤1.1 mT1s tumors, respectively (p = 0.003). We showed that the level of pigmentation in M3/8g LMUM identified two subsets that were correlated with distinct clinical outcomes.
Highlights
Uveal melanoma (UM) is the most frequent primary malignancy of the eye in adults, and it exhibits molecular and pathologic features that differ from those of cutaneous melanoma [1]
We found that high-genetic-risk liver metastases of uveal melanoma (LMUM) tended to have lower melanin pigmentation as assessed by magnetic resonance imaging (MRI) T1 signal, while low/intermediate-genetic-risk LMUM exhibited higher T1 signals
We discovered that M3/8g LMUM with poor prognosis can be subdivided into two subsets based on melanin MRI quantification that correlated with distinct clinical outcomes (18 months vs. 30 months for mean T1 signal (mT1s) > 1.1 and ≤ 1.1 LMUM, respectively)
Summary
Uveal melanoma (UM) is the most frequent primary malignancy of the eye in adults, and it exhibits molecular and pathologic features that differ from those of cutaneous melanoma [1]. Despite effective local treatment of the primary ocular tumor, metastatic spread occurs in 50% of patients, with the liver being the most common site [2]. Various systemic treatments (chemotherapy, antiprogrammed cell death protein 1, target therapies, vaccine) were investigated in cases of liver metastases of uveal melanoma (LMUM) with disappointing results to date [3]. For metastatic patients eligible for surgery, resection of LMUM is associated with the best OS rates published to date [6]. LDH level and disease-free interval (DFI) between the primary ocular tumor and liver metastases were identified as independent prognostic factors of survival [7]. Higher pigmentation level in ocular uveal melanoma is related to a higher risk of metastasis and death [13,14]. The T1 shortening effect of melanin is likely based on the binding of paramagnetic metal ions [19]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.